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The spread of bacterial resistance to antibiotics poses the need for antimicrobial discovery.
With traditional search paradigms being exhausted, approaches that are altogether different
from antibiotics may offer promising and creative solutions. Here, we introduce a de novo
peptide topology that—by emulating the virus architecture—assembles into discrete anti-
microbial capsids. Using the combination of high-resolution and real-time imaging, we
demonstrate that these artiﬁcial capsids assemble as 20-nm hollow shells that attack bac-
terial membranes and upon landing on phospholipid bilayers instantaneously (seconds)
convert into rapidly expanding pores causing membrane lysis (minutes). The designed
capsids show broad antimicrobial activities, thus executing one primary function—they
destroy bacteria on contact.
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Antibiotic resistance presents signiﬁcant challenges forhealthcare1. Conventional antimicrobial strategies thattarget individual intracellular processes continue facing
the same barriers of rapidly acquired resistance2, impermeable
bacterial membranes3 and the tolerance of quiescent bacteria to
antibiotic treatments4. These are just a few factors that prompt
the development of novel antimicrobial agents that would be
compatible with mammalian immune systems, would not dif-
ferentiate between growing and dormant bacteria and whose
activity does not rely on reaching intracellular targets. In this
regard, host defense peptides provide a promising source of
antimicrobial agents5. These molecules are evolutionarily con-
served components of the innate immunity that are found in all
living organisms. Despite their apparent diversity, the peptides
share common characteristics. They fold into amphipathic
structures in response to membrane binding, are cationic and
cause disrupting pores, channels or carpets in microbial phos-
pholipid bilayers6. To realise these modes of action, the peptides
must translate from an inactive surface-bound (“S”) state to an
active and antimicrobial pore-like insertion (“I”) state7. This
transition necessitates the localised oligomerisation of individual
peptides in membranes that would be able to overcome a
threshold barrier—a critical local concentration above which
antimicrobial effects become apparent. Removing this barrier by
locally delivering concentrations that greatly exceed the threshold
concentrations may introduce strategies with potentially faster
and more profound antimicrobial responses that are less subject
to acquired resistance.
Here, we show that artiﬁcial virus-like capsids assembled from
de novo antimicrobial peptide sequences provide such a strategy.
These designed capsids assemble as 20-nm hollow shells that
favour attack on bacterial membranes and upon landing on
phospholipid bilayers instantaneously convert into rapidly
expanding pores causing bacterial lysis within minutes. We
demonstrate that these capsids exhibit broad antimicrobial
activities, thus executing one primary biological function. They
destroy bacteria on contact.
Results
Capsid design principles. Our approach is a retro design that
aims to encode a pore-forming oligomerisation state into a dis-
crete pre-assembly of antimicrobial peptides. Since membrane-
disrupting pores need not exceed tens of nanometres, the
resulting assembly has to be structurally conﬁned to avoid
aggregation, an order of magnitude smaller than a bacterial cell
(0.2–2 µm) to instantaneously convert into membrane-lysing
pores, and functionally inert (non-toxic) to mammalian cells. The
viral capsid architecture offers a suitable self-assembly form that
is symbiotic to mammalian host cells and can meet all of these
requirements. Viruses do not disrupt microbial membranes, are
not typically antimicrobial, but their capsids offer an ideal,
amenable architectural platform for designing artiﬁcial capsids
assembled from antimicrobial sequences. Such synthetic capsids
have a primary biological function of destroying bacterial mem-
branes on contact.
Native capsid proteins assemble according to an n-fold
rotational symmetry, which imposes geometric constraints on
allowed protein folds and interactions. Often it means that more
protein subunits or subunit proteins are used in a capsid. Any
capsid can be described using the concept of quasi-equivalent
positions. The concept offers an approach whereby capsid
proteins are packed around the surface of a sphere with a cubic
symmetry, may be positioned in similar environments (quasi-
equivalent) with respect to each other, and are clustered into
closed supramolecular networks8. These principles are universal
and pertinent to viruses from different taxonomic groups: human
(adenoviruses), plant (cowpea mosaic viruses), animal (porcine
parvovirus), algal (phycodnavirus) or bacterial (tailless phage)
capsids are all proteinaceous icosahedra9. An icosahedron
consists of 20 ﬂat faces of equilateral triangles arranged around
a sphere with 5/2 3 symmetry (Fig. 1a).
Each face is subdivided into smaller triangles, facets, and their
number is reﬂected in a triangulation number T, which can be
found graphically from an equilateral triangular net and using a
simple equation:
T ¼ k2 þ k ´ hþ h2; ð1Þ
where k and h are any integers with no common factor (Fig. 1b).
Capsids with low triangulation numbers would have low
numbers of different polypeptide sequences and subunits in the
assembly (Fig. 1c). Indeed, a T = 1 capsid has 20 triangular faces
and each triangle can be subdivided into three equal portions
each hosting one protein (Fig. 1a). A total of 60 identical proteins
would make up a T = 1 capsid (Fig. 1d). Any T> 1 icosahedron
has 20 × T faces, 12 pentamers (ﬁve-fold vertices) and 10 × (T–1)
hexamers. As a consequence, protein numbers in capsids increase
with increasing T numbers, e.g. T = 3 (180 proteins), T = 4 (240)
and so on. The capsid symmetry is ensured by the arrangement of
protein subunits around ﬁve- and six-fold vertices into penta-
meric and hexameric supramolecular units, respectively (Fig. 1b).
Capsid proteins interface via precisely matched orthogonal
interactions10, which remain challenging to emulate de novo.
To mitigate the need for such orthogonal ﬁtting, the same
protein motif can be placed at each triangular vertex, whereas
each triangle must retain the three-fold symmetry (Fig. 1a). To
accommodate this requirement, we designed a rigid C3-triskelion
to occupy a triangle (Fig. 1e). Two triskelion arrangements within
a triangle are possible, leading to two different propagation
modes, “starburst” and “honeycomb” (Fig. 1e). Each adapts a
classical 5/2 3 capsid symmetry, and each requires the triskelion
to propagate at its termini. However, the “honeycomb” propaga-
tion, albeit successfully exploited for the design of peptide shells,
relies on interfacial “sticky” interactions, oblique or orthogonal11–
17. These use naturally occurring peptides, typically forming β-
pleated structures, that assemble into amyloid-like aggre-
gates11,15–17, and artiﬁcial helices whose assembly depends fully
on stabilisation via disulphide bridging13 or beneﬁts from it12,14.
Three-arm dendrimers or three-directional, non-covalent branch-
ing hubs in this mode propagate at two-fold axes of symmetry,
with agglomeration and ﬁbrillogenesis being common side
reactions13–15. Strong binding at two-fold axes is crucial as the
ﬁve- and six-fold vertices are deemed largely hollow and
redundant18. Therefore, only short triskelions or orthogonal C3-
branching can afford tight packing supporting this mode of
propagation. By contrast, the “starburst” arrangement is better
suited to direct a capsid-like assembly. It is enabled by all three
C3-termini clustering at ﬁve- and six-fold axes and can readily
translate into any T> 1 assembly. The three equivalent legs of
each triskelion provide the three altitudes of a triangle. Therefore,
the edge of a triangular unit is a common integer for all units in an
icosahedron face, irrespective of their number (Fig. 1b, c). Based
on these principles, we engineered an antimicrobial protein motif
arranged into a C3-triskelion that by clustering at its leg termini
with other triskelion copies assembles into capsid-like shells.
An elementary C1-subunit. To provide a triangular unit, each leg
of a triskelion must be a rigid, rod-like structure. A protein
folding motif to provide this property is an α-helical coiled coil19.
The motif is ubiquitous for different viral processes ranging from
capsid assembly (hepatitis B virus) to membrane fusion (HIV)
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20,21. Coiled coils are bundles of interdigitated α-helices, the
number of which can be rationally controlled. In viruses, how-
ever, the motif is predominantly heterodimeric and packs further
forming four- and six-helix bundles20–22. Canonical coiled coils
are characterised by heptad repeats of hydrophobic and polar
residues, typically designated abcdefg, in which a and d form
hydrophobic interfaces23. In order to form contiguous interfaces,
the a/d patterns of corresponding helices must be in register. Yet,
the average spacing of hydrophobic residues along a coiled-coil
sequence is 3.5 residues, which is less than one complete turn (3.6
residues) of a monomeric α-helix19. To rectify this discrepancy, a/
d patterns impose a slight left-handed twist, enabling left-handed
helix-crossing angles in the coiled-coil bundle. This permits stable
coiled-coil formation. Complementary electrostatic interactions
at e and g sites of successive heptads between partner strands (i.e.
g–e′ interactions: g of one heptad and e′ of the following heptad
on the other helix) stabilise the coiled coil24. Recently, we have
expanded the assignment of coiled-coil patterns into naturally
occurring and de novo antimicrobial sequences25–27.
For engineering antimicrobial coiled coils, it is necessary to
consider hydrophobic a/d pairs in conjunction with charged g/e′
pairs25. In this case, a coiled-coil heterodimer would have an
antimicrobial cationic strand and a complementary anionic
strand. To enable such a dimer, we made a/d pairs isoleucine/
leucine, thus emulating native leucine-zipper structures, while
cationic lysines (antimicrobial strand) and anionic glutamates
(antagonistic strand) were used for complementary g/e′ pairs
supporting parallel heterodimers. Additional lysine residues were
introduced into the solvent-exposed c sites of the antimicrobial
strand to facilitate coiled-coil disassembly upon binding to
microbial membranes. The other solvent-exposed positions, b and
f, were occupied by alternating neutral polar glutamines and small
alanines. In the anionic strand, serine residues alternating with
alanines in b and c positions were used to promote peptide
solubility, with f sites taken up by glutamines. Given the
minimum requirement of three contiguous heptads to form
stable coiled coils28, and that antimicrobial sequences of similar
lengths are appreciably strong29, each strand was made as a 21-
mer (Fig. 2a–d, Supplementary Fig 1 and 2). This dimeric coiled
coil offered an elementary geometric building block—an
anisotropic, rod-shaped 3.2 × 2-nm C1-subunit (Fig. 2e).
Circular dichroism (CD) spectroscopy revealed that individu-
ally the peptides remain unfolded in solution, while helix
formation was essentially complete (>90%) for their equimolar
mixtures (Supplementary Fig 3a). The folding of the C1-subunit
proved to be highly cooperative as gauged by nearly sigmoidal
unfolding curves30 with a dominating transition midpoint (TM)
of ~50 °C (Supplementary Fig 3b), and by the constant signal
intensity at 202 nm during thermal denaturation, which provided
a clear isodichroic point typical of a two-state, helix-to-coil,
transition (Supplementary Fig 3c). The transition was also fully
reversible as spectra recorded before and after the melt were
nearly identical (Supplementary Fig 3d). As expected, no
assemblies were observed for this elementary subunit by
transmission electron microscopy (TEM) (Supplementary Fig 4a).
For it to be placed at the triangular vertices and to endow it with a
capsid-like symmetry, further modiﬁcations were necessary.
A capsid C3-subunit. First of all, three copies of the C1 (+) strand
were conjugated onto a triskelial hub (Fig. 2f and Supplementary
Fig 1). Each leg of the resulting structure folded with the C1 (–)
strand giving rise to a rigid C3-triskelion (Fig. 3a).
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Fig. 1 The geometry of viral capsids. a Schematic representation of an equilateral icosahedron; 20 ﬂat triangular faces and 12 vertices are arranged around a
sphere and related by ﬁve-, three- and two-fold axes of rotational symmetry (diamond, triangle and rectangle, respectively). With each triangular face
hosting three protein subunits (arrows at the vertices), 60 equivalent subunits in total, the icosahedron becomes a T= 1 capsid. b Equilateral triangular net
relating icosahedral and quasi-equivalent symmetries. Each triangulation (T) number is calculated from (h, k) and denotes the number of smaller triangles
arranged around local quasi-6-folds in one triangular icosahedron face. c The net folded into an icosahedron showing different T numbers in individual
triangles: (clockwise) 1, 4, 9, 16 and 25. d Native virus (T= 1) capsid unfolded into a triangular net with three identical subunits in each triangular face. The
ﬁgure (Vdb 898, PDB 2GSY) was obtained from VIPERdb (http://viperdb.scripps.edu)9. e Two arrangements of a C3-triskelion within a triangular unit
leading to “starburst” and “honeycomb” propagation modes. In the starburst mode, the three equivalent legs of the triskelion serve as the altitudes of the
triangle. Two variations of the honeycomb triskelion arrangement, symmetrical and asymmetrical, are given. For clarity, central triskelions are shown in
orange
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All three legs are folded and identical, all carry a large positive
net charge, which provides electrostatic repulsions, all have polar
solvent-exposed faces with no complementary interactions and
none can support anti-parallel coiled-coil formation. This rigid
C3-subunit ﬁrmly ﬁts into a triangular face, but cannot yet
assemble. In accord with this, particulate structures with sizes of
the subunit (5.3± 1.5 nm), and without higher order assemblies,
were observed by TEM (Supplementary Fig 4b, c). Dynamic Light
Scattering (DLS) provided complementary evidence by revealing
an average hydrodynamic diameter of 5.25± 0.61 nm for the
subunit in solution (Supplementary Fig 4d, e). Therefore, we set
out to promote a directed aggregation of triskelions via their
termini.
To enable this, the N-terminus of the C1 (−) strand was
extended with a cysteine cap (Figs. 2a, e and 3a and
Supplementary Fig 1). Cysteines, in both reduced and oxidised
forms, have the highest hydrophobicity among the proteinogenic
amino acids, possess high propensity for secondary structure and
are capable of localised, proximity-driven cross-linking14,31.
Buried, unpaired cysteines are known to induce particle
formation in antibodies providing interfacial hydrophobic
clustering accompanied by non-native cystine formation32.
Similarly, viruses, in which native disulphide bonds are reduced
or replaced, retain their ability to assemble into wild-type
forms33,34. Collectively, these factors suggest that C3-oriented
N-terminal cysteines of the triskelions should promote hydro-
phobic clustering at the vertices of triangular facets resulting in a
capsid-like assembly. Consistent with this, DLS measurements
gave average diameters of 21.2± 5.3 nm indicating the formation
of higher order assemblies with a relatively narrow size
distribution (Supplementary Fig 4f, g). It should be noted,
however, that DLS is limited in size resolution by the factor of 3,
which may not be sufﬁcient to resolve complex and narrow
distributions. Therefore, we sought more accurate evidence. The
assembled capsids were analysed by high-resolution TEM, which
showed broadly uniform paracrystalline phases with an average
diameter of 18 nm (Fig. 3b). The importance of this ﬁnding is
three fold.
Firstly, it supports a structural plasticity of the assembled
capsids within a narrow size range. Such polymorphism is indeed
common among viruses that can tune packaging symmetry to
compensate for size variations35. As a rule, these changes are
reﬂected in different T numbers36. For example, cowpea chlorotic
mottle virus can repack from T = 3 (28 nm) into T = 1 (18 nm)
capsids37. In our design, each leg of the folded triskelion (from
the centre of the dendrimer hub to the acetylated N-terminus of
C1 (−) strand) spans approximately 4 nm (Fig. 3a). This makes
the side of an equilateral triangle ~6.1 nm, which falls within the
sizes observed by TEM (Supplementary Fig 4b, c). A T = 1
assembly is deemed unstable and geometrically disfavoured as the
triskelions cannot arrange around six-fold axes in this capsid
(Fig. 1e and Supplementary Fig 5). Therefore, smaller assemblies
observed by TEM are likely to be aberrant or incomplete capsids
(Fig. 3b, c). Since the triskelions can only pack into equilateral
triangular facets, the next possible assembly, in which triskelia
termini cluster into clearly deﬁned six- and ﬁve-fold symmetries,
is a T = 4 capsid of ~20 nm in diameter (Fig. 3d, e and
Supplementary Fig 5). Triskelions readily ﬁt into this capsid
(Fig. 3e), which is amply complemented by the most abundant
diameters observed by TEM (Fig. 3b, c).
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Fig. 2 An elementary capsid C1-subunit. a The linear sequences of the subunit. Antimicrobial (C1 (+) strand) and antagonist (C1 (−) strand) sequences are
shown in blue and red, respectively, and are aligned under the coiled-coil heptad repeat pattern, gabcdef. The cysteine residue is shown in yellow. Crossed
arrows show electrostatic interactions. Unengaged positively charged lysines are highlighted with “+”. These confer the dimer with an overall positive
charge facilitating the binding of the subunit to anionic microbial membranes (see also Supplementary Table 1). b The sequences conﬁgured onto a coiled-
coil helical wheel with 3.5 residues per turn. Curved double-headed arrows indicate electrostatic interactions between g and e′ (circled) residues. Crossed
arrows show the hydrophobic interface of the dimeric subunit formed by isoleucines and leucines in a and d, respectively. c The linear sequence of the C1
(+) strand. Monomeric (i, i + 7) and coiled-coil (i, i + 3 and i, i + 4) helical spacings are shown, one of each for clarity. d The sequence of the C1 (+) strand
conﬁgured onto a monomeric helical wheel with 3.6 residues per turn, showing the clustering of amino-acid residues into two distinctive polar and
hydrophobic faces. e Molecular model of the coiled-coil C1-subunit (PDB entry 4DMD, rendered by Macromodel Schrödinger). f The chemical structure of
a dendrimer C3-hub used to make the C3-triskelion, C3 (+) strand. βA denotes beta-alanine (see also Supplementary Fig 1)
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Secondly, regardless of size variations, viral capsids maintain
their shell-like morphology. To gain a better insight into this for
the design, C3-capsids were analysed using cryo-TEM and
tomography that revealed hollow shells having diameters in the
same range observed by high-resolution TEM (Fig. 4a, Supple-
mentary Fig 6). It should be noted that cryo-EM reconstructions
provide attainable resolution in the 5–10-nm range38, which
borders the size of the triskelion shells. Therefore, three-
dimensional (3D) volume reconstructions of the obtained images
were ﬁtted into 24-nm spheres39, matching predominant
diameters of 20–24 nm, and were benchmarked against larger
(>100 nm) shells of the HIV-1 core assembly used for
comparison40. Returned reconstructions conﬁrmed the assembly
of C3-capsids as spherical, hollow shells (Fig. 4b–d). In accord
with the data, atomic force microscopy (AFM), which provides an
ideal probe for the analysis of morphologically deﬁned assem-
blies, revealed globular capsids with a similarly narrow size
distribution under both in-air and in-solution imaging conditions
(Supplementary Fig 7a, b). Notably, sizes measured by AFM in
solution closely matched those observed by DLS (Supplementary
Fig 7b and 4f).
Thus, thirdly, the geometrically conserved shells established for
the design manifest a synergy between the assembly and folding
of C3-subunits. Consistent with this, C3-capsids were found to
retain the strong helicity of the elementary C1-subunit (Supple-
mentary Figs 3a and 8a). Both CD and Fourier transform infra-
red spectroscopy (FTIR) spectra for the capsids were character-
istic of α-helical conformations, with elements of a β-turn
structure that could be assigned in the FTIR spectra being
attributable to the dendrimer hub (Supplementary Fig 8b). In
particular, the amide I band in the spectra appeared to be red-
shifted (1650± 2 cm−1) from the values expected for a
monomeric α-helix (1656± 2 cm−1), indicating helical adjust-
ments for the coiled-coil formation in the C3-subunits (Supple-
mentary Fig 8b)41. These adjustments proved to be cooperative as
reﬂected in gradual increases in helicity as a function of
increasing concentrations of the C1 (–) strand titrated into the
C3 (+) strand (Supplementary Fig 8c)42,43. Plotting these increases
versus the concentrations revealed a saturation ratio of 3 for the
C1 (–) to C3 (+) strands and a single binding afﬁnity value (KD) of
32± 5.6 µM44 (Supplementary Fig 8d). At this ratio, the assembly
thermally denatured (20–90 °C) returned sigmoidal unfolding
curves, with helical spectra recorded every 1 °C sharing the same
signal intensity at 202 nm (Supplementary Fig 8e, f), which
indicates a clear one-state transition comparable to that observed
for the elementary unit (Supplementary Fig 3). Taken together,
these ﬁndings conﬁrm the cooperative assembly of the C3-capsids
and the complementarity of coiled-coil interactions and cysteine-
promoted hydrophobic clustering. More speciﬁcally, complemen-
tarity ensures that each C3-subunit is stabilised as a rigid,
autonomous structure, while cysteine caps encourage the
formation of a hydrophobic network at vertices. Proximity-
driven cross-linking of the caps can accompany the clustering,
but is not necessary, with the variation of odd and even numbers
of cysteines available at the vertices. Indeed, comparative
quantiﬁcations by Ellman’s test gave up to 25% reductions in
the concentration of free thiols in the capsids, conﬁrming a partial
disulphide formation. Such a dual stabilisation function—
clustering and cross-linking—allows the assembly to maintain
the anisotropic packing of spatially restricted C1-subunits at the
vertices facilitating the formation of a well-hydrated shell.
Antimicrobial activity and mechanism of C3-capsids. To elicit
the biological activity, the design has two main modes of folding,
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Fig. 3 Capsid-like assembly of the C3-subunit. a Molecular model of the C3-triskelion (PDB entry 4DMD rendered by Macromodel Schrödinger). Each
subunit of the triskelion corresponds to the altitude of an equilateral triangle. A folded subunit spans ~4 nm (three coiled-coil heptads extended with the
arm of the dendrimer hub and the cysteine cap), which makes the side of the hosting triangle ~6.1 nm. b High-resolution electron micrographs for C3 (+)
strand (100 µM) assembled with C1 (−) strand at 1:3 molar ratio, with individual structures highlighted by white squares. Scale bars are 100 nm for the large
panel and 20 nm for the four inset images of individual assemblies. c Diameter distributions of the assembled capsids with corresponding sizes calculated
for the triskelion ﬁtted into a triangular facet (C3) and T capsids. d T= 4 icosahedron with four facets in each triangular face with each accommodating one
triskelion. For clarity, only a partial network of triskelions in the icosahedron is shown. Five- and six-fold axes are highlighted by yellow diamonds. The
diameter of the icosahedron and the side of its triangular face are calculated based on the triskelion dimensions shown in a. e Model of a T= 4 capsid
assembled from the C3-subunit with parameters matching those from a and d. For clarity, only one of ﬁve- and six-fold axes each is shown in colour and
with cysteines
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each supporting a speciﬁc function. The assembly is stable in
solution as well as in the presence of mammalian cell membranes.
The capsids, however, are expected to bind to microbial mem-
branes, which is followed by their disassembly into two inde-
pendent components—the antimicrobial C3 (+) triskelion that
folds and inserts in the microbial phospholipid matrix, and the C1
(−) strand, the anionic antagonist, which cannot bind to cellular
membranes, and instead converts into a random coil remaining
in solution. This renders the capsids differential in attacking
microbial, but not mammalian, membranes. To probe this
behaviour in isolation from intracellular processes45,46, which
may indirectly involve in the antimicrobial activity, the folding of
the components was measured in the presence of zwitterionic and
anionic unilamellar vesicles (ZUVs and AUVs) mimicking
mammalian and bacterial membranes, respectively. Two lipid
types, saturated and unsaturated, were used to assemble the
vesicles. 1,2-Dilauroyl-sn-glycero-3-phosphocholine (DLPC) and
its 3:1 molar mixtures with 1,2-dilauroyl-sn-glycero-3-phospho-
(1′-rac-glycerol) (DLPG) were used for the corresponding
assembly of ZUVs and AUVs. Thicker, unsaturated and more
asymmetric membranes were assembled from 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-hex-
adecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-
glycerol) (POPG) lipids. All these compositions give ﬂuid-phase
membranes at both room and physiological temperatures,
allowing for the direct assessment of membrane-disrupting effects
in solution. As expected, the C3 (+) triskelion folded only in
AUVs, while the C1 (−) strand did not fold at all (Supplementary
Fig 9). These differences correlated with biological activities.
Namely, the C3 (+) triskelion and the assembled capsids were
strongly antimicrobial with no apparent haemolytic activities at
micromolar concentrations. Minimum inhibitory concentrations
(MICs) were typical of polypeptide antibiotics within the phe-
notypic tolerance of bacteria to antibiotics47, while the C1 (−)
strand was biologically inactive (Table 1).
The seemingly lower MICs of C3-capsids are for the total
peptide concentrations; that is, for 1:3 molar ratios of C3 (+)
triskelions co-assembled with C1 (−) strands. Therefore, the actual
active concentration of the triskelions in the assembled capsids is
decreased by to a factor of 4 (Table 1). In principle, higher MICs
for the capsids could also be accounted for by a partial
antagonistic action of the C1 (−) strand on the C1 (+) strand
inhibiting membrane binding. To be apparent, however, this
action requires substantially higher ratios25. Nonetheless, for the
reasons of avoiding strong antagonistic effects of the C1 (−)
strand, each heptad of the C1 (+) strand incorporates an
additional lysine residue contributing a positive charge that is
not engaged in coiled-coil formation, is solvent exposed and
hence is available for binding to microbial membranes (Fig. 2a-d).
Since in their native environments antimicrobial peptides are
secreted to act within their proteolytic life time (minutes), the
antimicrobial action of capsids should be evident within similar
timescales. MIC assays cannot access such timescales because
these tests are optical density measurements performed over
much longer periods of time (24 h).
To gain a better insight into killing kinetics at the cellular level,
we monitored the lysis of Gram-negative Escherichia coli and
Gram-positive Bacillus subtilis using one-stain (propidium
iodide) and two-stain (LIVE/DEAD® BacLightTM) bacterial
viability assays in conjunction with ﬂuorescence microscopy
(Supplementary Fig 10). For both bacteria, the capsids used at the
MIC (3 µm) caused progressive lysis of up to 80% of the total
number of cells within the ﬁrst 20 min reaching nearly complete
killing rates in 30 min (Supplementary Fig 10). Collectively, the
results of the biological tests indicate strong and rapid
antimicrobial responses of the C3-capsids, suggesting a physical,
membrane-mediated mechanism of action. Indeed, once in
membranes C1 (+) strands are meant to refold and insert in
phospholipid bilayers in a transmembrane manner46. Because all
three legs in the C3 (+) triskelion are identical, each has the same
C3-capsid
C3-capsid
HIV (EMDB 1155)
a c
d
b
Fig. 4 C3-capsids in 3D. a Cryo-electron micrographs of assembled C3-capsids. Scale bars are 10 nm. b Representative cryo-electron tomography (z-planes)
for an assembled C3-capsid. Scale bar is 20 nm. c 3D rendering of the capsids. Volume reconstruction for a C3-capsid is ﬁtted to a sphere with a radius of
12 nm showing the exterior of the capsid in yellow and its side and top cross-sections. Molecular graphics and analyses were performed using UCSF
Chimera package39. Chimera is developed by the Resource for Biocomputing, Visualisation and Informatics at the University of California, San Francisco
(supported by NIGMS P41-GM103311). d 3D rendering of HIV-1 core shell (EMDataBank entry 1155) shown for comparison. The volume reconstruction,
with the exterior and interior shown in yellow and red, respectively. Note: not to scale, HIV particles are >100 nm in diameter
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ability to bind and insert. Because the length of each strand
matches the thickness of the phospholipid bilayers (3–4 nm), this
ability is not restricted, but facilitated by the other two strands of
the triskelion that remain lipid bound. Finally, given that in
membranes all the strands would have the same orientational
preference, for which they compete, triskelions are anticipated to
inﬂict an immediate membrane damage leading to the progressive
removal of the bilayer. Consequently, C3-capsids are predicted to
porate phospholipid bilayers with the formation of large and
expanding transmembrane pores.
It should be noted, however, that microbial membranes are
curved 3D structures that do not exceed 2 µm in size. Poration in
these membranes can lead to rapid membrane rupture and
collapse before individual pores can expand visibly. Longer time
and length scale studies are necessary to observe the predicted
effect, which can be accessed in supported lipid bilayers (SLBs).
These preparations give ideal models for ﬂuid-phase membranes
and are ﬂat (to within ~0.1 nm) in their unperturbed state,
thereby ensuring the most accurate depth measurements of
forming pores in real time by AFM45. With this in mind, we
visualised the effect of C3-capsids on SLBs prepared by the surface
deposition of AUVs in aqueous solution46, using an AFM
adapted for high-speed scanning48 and compiling videos
(Supplementary Movie 1) based on sequences of rapidly acquired
AFM images49. Upon the addition of the capsids, poration was
apparent within seconds of incubation, indicating the instanta-
neous disassembly of the capsids on the membranes (Fig. 5a and
Supplementary Movie 1). The formed pores grew in size and
merged resulting in the complete removal of the available
phospholipid matrix under 5 min (Fig. 5a). The depths of the
pores were consistently ~3 nm, indicating that C1 (+) strands
spanned the bilayer (Fig. 5b and Supplementary Movie 1).
The data prompt a mechanism according to which C3-capsids
at once disassemble upon landing on membranes, whereupon C3-
triskelions re-assemble into transmembrane pores—all within
several minutes. The orientation of C1 (+) strands incorporated
into the bilayer is likely to be in a dynamic equilibrium with the
other strands in the same C3 (+) triskelion whose membrane
binding must be equally satisﬁed. On the one hand, such a
demand for each C1 (+) strand to bind and fold with the lipids
promotes profound membrane disruption manifesting in rapidly
expanding pores (Fig. 5). On the other hand, a thicker
peptidoglycan layer on the surface of Gram-positive bacteria that
is rich in anionic teichoic polymers might initiate the premature
disassembly of the capsids, while inhibiting the migration of
folded triskelions to the cytoplasmic membrane50. Partly, this
may explain the less pronounced activities of the capsids against
Gram-positive Staphylococcus aureus and Enterococcus faecalis
(Table 1). By contrast, Gram-positive B. subtilis, whose
peptidoglycan undergoes continuous transformations from thick
to thin layers51, was noticeably more susceptible to the treatment
of the capsids (Table 1). Encouragingly, this property of the
capsids to respond differentially to bacterial membranes can be
harnessed for targeting Gram-negative membranes, in which case
membrane-selective capsids could be developed.
Discussion
The demonstrated concept offers a molecular platform for engi-
neering bespoke antimicrobial capsids that can be assembled
from relatively short amino-acid sequences. Given that there are
thousands of antimicrobial peptides reported in the literature5,6,
each of these may be used to construct a self-assembling capsid
protomer. Antimicrobial sequences are certainly not limited to
stand-alone peptides, naturally occurring or designed, and can be
sourced from native proteins exhibiting complementary proper-
ties. For example, short peptide fragments of transmembrane
proteins or bacteriostatic proteins from biological ﬂuids can be
redesigned to assemble into biologically functional nanoscale
shells17,52. The use of antagonistic sequences that co-fold with
antimicrobial sequences introduces another level of control when
compared to structures assembled exclusively from antimicrobial
components17. Resulting hetero-oligomers give rise to discrete
protomers for which number in a ﬁnal assembly can be pre-
deﬁned in a manner similar to the aggregation number of capsids
used to describe viruses9. Not only this supports geometrically
conserved structures with a narrow size distribution, as demon-
strated here, but can also provide a means of tuning discrete
capsids or their ensembles within close T > 1 ranges.
In principle, this ability would be important in addressing
broader aspects of antimicrobial activity including the targeting of
intracellular pathogens. Conventional antibiotics are of little help
against these, and particularly against dormant forms that are
phenotypically tolerant to antibiotic treatments53. Similar to
antimicrobial peptides, which, unlike antibiotics, attack both
growing and mature bacteria29, the designed peptide capsids may
prove effective in this regard: their differential membrane binding
is directly related to their ability to traverse mammalian
Table 1 Biological activities of peptides used in the study
Cell Peptidea
C3 (+) strand C3-capsid Cecropin B Daptomycin Polymyxin B Gramicidin S
Minimum inhibitory concentrations, µMb
P. aeruginosa (ATCC27853) 3 12 <2 >100 <1 >40
S. aureus (ATCC6538) 50 >100 >100 <8 <50 <20
E. coli (K12) 1.5 3 <1 >100 <1 <20
B. subtilis (ATCC6633) 1.5 3 >50 <8 1.5 >40
S. enterica (ATCC700720) 3 3 3 >50 <1 <10
E. faecalis (OG1X) 50 >50 <25 >100 >100 ND
K. pneumoniae (NCTC 5055) >12 <25 <1 >50 <1 ND
(LC50), µMc
Human erythrocytes >250d >250 >250 >250d UD >20
All tests were done in triplicates
UD undetectable, ND not determined
aC1 (−) strand was inactive (>250 µM)
bTotal peptide concentration
cMedian (50%) cell death compared to untreated cells
dHaemolysis of <10% observed at higher concentrations
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membranes and reach the cytoplasm without cytotoxicity. Anti-
microbial sequences have built-in cell-penetrating properties, so
do the designed capsids. Furthermore, the capsids may encap-
sulate genetic cargo or a reporter and deliver it into the cytoplasm
of human cells, which may provide a dual function of cell
penetration and delivery. To probe the feasibility of intracellular
delivery, the capsids were co-assembled with a model RNA that
was ﬂuorescently labelled. The resulting capsids promoted an
active RNA delivery into HeLa cells within hours (Supplementary
Fig 11a). The ﬂuorescent RNA appeared as particulate cyto-
plasmic spreads in the cytoplasm suggesting an endocytic
uptake14. Flow cytometry measurements showed that the trans-
fection efﬁciency of the capsids was at least comparable with that
of commercial transfection reagents (Supplementary Fig 11b, c),
whereas RNA mixed with the C1 (−) strand, as a negative control,
showed no transfection (Supplementary Fig 11d). Thus, the
capsids are effectively infectious agents whose cellular and
intracellular targeting can be enhanced by incorporating specialist
moieties allowing for receptor-mediated delivery.
In more practical terms, whereas better antibiotics inevitably
lead to a ﬁtter resistance, the concept entails a promising dis-
covery paradigm. The clinical potential of antimicrobial capsids
owes to the lack of widespread microbial resistance to anti-
microbial sequences5. Membrane disrupters impose a prohibitive
cost for bacterial resistance to develop6, but yet their action is
bound to the same “S”-to-“I” transition of individual peptide
monomers. By contrast, pre-concentrating the monomers into
capsids introduces a principally more challenging scenario of
virtually built-in pores that can instantaneously convert into
irreparable membrane lesions in bacterial cells.
Indeed, the designed capsids are weakly cationic, which might
allow them to cross biological barriers more effectively (Supple-
mentary Table 1). For example, particles with strong cationic
surfaces are not effective in crossing blood–brain barrier, which
remains a major obstacle for their therapeutic uses14. Native
viruses have isoelectric points (pI) below 8, but which can extend
due to sorption processes, while for highly infectious viruses such
as polioviruses pI can be >854. The designed capsids possess a
weak positive charge that is sufﬁcient to bind to anionic bacterial
surfaces, and upon binding the capsids disassemble with a rapid
increase in pI (to 11 as that of the C3 (+) strand), thus effectively
binding membrane phospholipids and disrupting the bilayer.
Most peptide-based antibiotics destroy bacterial cell mem-
branes (colistin) or inhibit their construction (vancomycin). With
the increasing usage of membrane-active antibiotics in clinic
(daptomycin, polymyxins) and a stronger drive towards anti-
biotics effective against Gram-negative bacteria, there is a press-
ing need to extend search strategies to alternative approaches
involving macromolecules that are different from antibiotics
altogether and may build upon similar, membrane-disrupting
mechanisms. For all these reasons, the described mechanistic
design lends itself to emerging classes of antimicrobial agents and
materials with a rich repertoire of exploitable properties.
Methods
Peptide synthesis. All the peptides were assembled on a Liberty microwave
peptide synthesiser (CEM Corp.) using standard Fmoc/tBu solid-phase protocols
with HBTU/DIPEA as coupling reagents (Supplementary Fig 1). Rink amide 4-
methylbenzhydrylamine resin was used throughout. Standard Allyl-based ortho-
gonal protocols were employed for the synthesis of the C3-triskelion on resin, with
Fmoc-Lys(Alloc)-OH used to generate the C3-dendrimer hub (Supplementary
Fig 1). The hub and the C1 (−) strand were acetylated using a solution containing
acetic anhydride (5%, v/v) and pyridine (5%, v/v) in DMF. Upon cleavage and
deprotection of cysteine-free peptides (95% TFA, 2.5% TIS, 2.5% water) and the C1
(−) strand (95% TFA, 2.5% TIS, 2.5% EDT), the peptide identities were conﬁrmed
by analytical RP-HPLC and MALDI-ToF (Supplementary Fig 2).
MS [M+H]+: C1 (−) strand—m/z 2545.8 (calc.), 2546.1 (observed); Cys-free C1
(−) strand—m/z 2371.6 (calc.), 2372.5 (observed); C1 (+) strand—m/z 2447.1
(calc.), 2447.3 (observed); C3-triskelion—m/z 8302.6 (calc.), 8302.6 (observed). MS
[M+Na]+: C1 (−) strand—m/z 2568.8 (calc.), 2569.3 (observed); Cys-free C1 (−)
strand—m/z 2394.6 (calc.), 2394.6 (observed); C3-triskelion—m/z 8325.5 (calc.),
8324.9 (observed).
High-performance liquid chromatography. Analytical and semi-preparative
gradient RP-HPLC was performed on a JASCO HPLC system using Vydac C18
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Fig. 5 C3-capsids porating phospholipid bilayers. a In-water AFM imaging of supported lipid bilayers treated with C3-capsids (3 µM total peptide).
Topography (height) images, captured at 13 s per frame, are shown. The time stamp corresponds to the middle line of each AFM scan, referenced to the
time (00:00) of capsid injection. White arrowheads indicate the AFM scan direction. The scale bar is 1 μm. b Cross-sections along the lines marked in (a,
−00:13 and 01:57) before (left) and after (right) the addition of capsids
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analytical (5 μm) and semi-preparative (5 μm) columns. Both analytical and semi-
preparative runs used a 10–60% B gradient over 40 min at 1 and 4.7 mLmin–1,
respectively, with detection at 230 and 220 nm. Buffer A—5% and buffer B—95%
aqueous CH3CN, 0.1% TFA.
CD spectroscopy. CD spectra were recorded on a Chirascan Plus spectro-
polarimeter (Applied Photophysics Ltd.) equipped with a Peltier temperature
controller. All measurements were taken in millidegrees using 1 nm step, 1 nm
bandwidth, 1 s time/point and four acquisitions. All measurements were recorded
in a quartz cuvette with 0.05 cm pathlength. Aqueous peptide solutions (300 µL,
100 µM total peptide, unless stated otherwise) were prepared in ﬁltered (0.22 µm)
10mM 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.4, room tempera-
ture. After baseline subtraction, the spectra were converted to mean residue
ellipticities (MRE, deg cm2 dmol−1 res−1) by normalising for the concentration of
peptide bonds and the cell pathlength. CD spectra at variable temperature were
recorded with a 1-°C step from 20 to 90 °C with 180 s equilibration time for each
spectrum. Thermal denaturation curves were obtained by plotting the MRE at 222
nm as a function of temperature, the ﬁrst derivative of which provided TM values.
Binding titrations were performed using module B end-station spectrophotometer
at B23 beamline (Diamond Light Source, UK) and a cylindrical cuvette with a 0.01-
cm path. All measurements were performed by titrating the C1 (−) strand into the
C3-triskelion (25 µM). Each sample for a speciﬁc molar ratio was incubated for 15
min prior to measurement. All measurements were taken in ellipticities and KD
values were calculated using Hills equation44. The thermal denaturation curve was
ﬁtted to standard two-state denaturation equations (dose response and Hills
equations). The calculations returned a nearly sigmoidal curve (Supplementary
Fig 3)30. The coefﬁcient of determination (R2) used as the measure of goodness of
ﬁt was 0.999 for the data versus 1 for an ideal ﬁt. CD spectra in the presence of
ZUVs and AUVs are for lipid–peptide (L/P) molar ratios of 100.
FTIR spectroscopy. All FTIR spectra were collected using a Tensor-37 series FTIR
spectrophotometer with a BioATR II unit (Bruker Optics, UK) as the sampling
platform with a photovoltaic mercury cadmium telluride (MCT) detector and a
Bruker Optics workstation, which was equipped with OPUS software. Low volume
(20 μL) peptide samples (100 μM) were placed in a circular sampling area of radius
2 mm with a pathlength of 6 μm. The temperature of the sample was maintained at
20 °C by means of ﬂow connectors to a circulating water bath. All FTIR spectra
were collected between 4000 and 850 cm−1 with a resolution of 4 cm−1, scanner
velocity 20 kHz, 128 scans, phase resolution 32 and zero ﬁlling factor 4.
Lipid vesicle preparation. The lipids DLPC and DLPG, and POPC and POPG
used for liposome construction were from Avanti Polar Lipids. The lipids were
weighted up, dissolved in chloroform–methanol (2:1, v/v), dried under a nitrogen
stream and placed under vacuum overnight. The resulting ﬁlm was hydrated to 10
mgmL–1 total lipid concentration in 10 mM phosphate buffer, pH 7.4. The sus-
pension was then extensively vortexed, sonicated (30 °C) and extruded (15 times)
through polycarbonate ﬁlters (0.05 μm) using a hand-held extruder (Avanti Polar
Lipids) to give a clear solution containing small unilamellar vesicles (SUV), which
were analysed (50 nm) by photon correlation spectroscopy using a Zetasizer Nano
(ZEN3600, Malvern Instruments, UK) following the re-suspension of vesicles to a
ﬁnal concentration of 1 mgmL−1. DLS batch measurements were carried out in a
low-volume disposable cuvette at 25 °C. Hydrodynamic radii were obtained
through the ﬁtting of autocorrelation data using the manufacture’s software, Dis-
persion Technology Software (DTS version 5.10).
Determination of free thiols. A stock solution of 5,5′-dithio-bis(2-nitrobenzoic
acid) (Ellman’s reagent from Pierce) was prepared to a ﬁnal concentration of 2 mM
in LC-MS grade water with 50 mM sodium acetate. Fifty microlitres of the solution
was mixed with 10 mM MOPS (pH 7.4, 100 µL) and LC-MS grade water (840 µL),
to take background absorbance. Pre-assembled capsids (10 µL, 100 µM, without
TCEP) were then added to the solution (ﬁnal volume of 1 mL); 200 µL of the ﬁnal
solution was scanned in the 280–600 nm region (automatic background subtrac-
tion) with recording absorbance at 412 nm. The absorbance for each sample was
calculated and the results were averaged and divided by 14,150M−1 cm−1
(extinction coefﬁcient of 2-nitro-5-thiobenzoate) and 1 (number of thiols in pep-
tide) to obtain the ﬁnal concentrations. Free thiol was quantiﬁed using a cysteine
standard curve prepared according to the proprietary protocol.
High-resolution TEM. Electron micrographs were recorded using a FEI Tecnai 20
twin lens scanning transmission electron microscope, operated at 200 kV. Droplets
of solution (8 µL) were placed on glow discharged Cu grids coated with pioloform
and carbon ﬁlm. After 1 min, the excess solvent was removed using a blotting paper
and the grid was stained with uranyl acetate (1%, wt) for 15 s before blotting the
excess stain. High-resolution images were recorded using a proprietary FEI Eagle
4k × 4k CCD.
Cryo-TEM. Cryo-TEM samples were prepared by plunge freezing performed using
a VITROBOT mark IV (FEI Company)—into liquid N2-cooled liquid ethane.
Droplets (5 µL) of peptide solutions (100 µM) were placed on glow discharged lacey
carbon grids and left for 2 s before blotting (2 s) and plunging. This yielded samples
in which peptide capsids are embedded in the vitreous ice suspended inside the
holes of the carbon. The sample grid was then transferred (without warming) into a
Gatan 626 cryo-holder and visualised at 200 kV in a Tecnai T20 (FEI company)
transmission electron microscope ﬁtted with an Eagle 4k × 4k camera (FEI).
Cryo-TEM tomography. The samples were prepared as above and tilt series were
collected automatically at 3° increments over an angular range of −42° to 55°. The
electron dose was 2.75 electrons per square Ångstrom per second per image.
Projection alignment, reconstruction and image processing were done using
IMOD. Visualisation, surface reconstruction and ﬁnal segmentation were per-
formed in Amira 3.0 (TGS, San Diego, CA).
In-air AFM. AFM images were obtained for a drop of peptide solution (8 µL, 100
µM) placed on a clean silicon wafer with the buffer excess removed by blotting. All
measurements were carried out on a Cypher instrument (Asylum research) in a
tapping mode using super-sharp PPP-NCHR type cantilevers (Nanosensors™:
resonant frequency ~330 kHz, tip radius of curvature <5 nm, force constant 42 N
m−1). Images were ﬂattened via line-by-line subtraction of ﬁrst-order ﬁts to the
background, using SPIP software, version 6.0.2.
Preparation of SLBs for AFM in water. SLBs were formed on mica as described
elsewhere45 from a vesicle solution of 4 mgmL−1 DLPC/DLPG (3:1, molar ratio)
and for POPC/POPG (3:1, molar ratio) SLBs. The vesicle solution was incubated
on cleaved mica for 30 min in 10 mM MOPS pH 7.2, with 5 mM MgCl2 and 5 mM
CaCl2. After absorption, the solution was washed 10 times with 10 mM MOPS pH
7.2, with 150 mM NaCl, to remove unfused vesicles from the solution. Mica discs
(Agar Scientiﬁc, Stansted, UK) were glued to a metal puck, and freshly cleaved
prior to lipid deposition.
In-water AFM on SLBs. Topographic images of SLBs in water were recorded on a
Multimode 8 AFM (Bruker AXS, CA, USA) with a modiﬁed AFM head designed
for the photothermal actuation of miniaturised cantilevers46. Bruker FASTSCAN-
D probes (0.25 N/m) (Bruker AFM probes, CA, USA) were photothermally driven
for Tapping mode at ~90 kHz with a typical amplitude setpoint of ~300 mV.
Capsids were introduced into the sample volume via a channel in the custom ﬂuid
cell and diluted in the existing buffer solution (150 mM NaCl, 10 mM MOPS pH
7.2) to the ﬁnal concentration stated. A negative Tapping mode setpoint was
applied to raise the cantilever above the sample surface during capsid injection.
Images of 2 μm size (256 × 256 pixels) were captured in alternate scan directions at
a line rate of 19.3 Hz. Images were processed using Gwyddion (http://gwyddion.
net/) for zeroth-order ﬂattening to centre data, and ﬁrst- or second-order plane
ﬁtting to remove tilt or bow. The time-lapse AFM video was generated from the
image sequence by using Fiji—Image J47. Cross-section measurements were carried
out using NanoScope Analysis or Gwyddion (http://gwyddion.net/) and plotted
using Origin (OriginLab, MA, USA).
MIC assay. MICs were determined by broth microdilution on different bacteria
according to the Clinical and Laboratory Standards Institute. Typically, 100 μL of
0.5–1 × 106 CFUmL–1 of each bacterium in Mueller Hinton media broth (Oxoid)
were incubated in 96-well microtitre plates with 100 μL of serial two-fold dilutions
of the peptides (from 100 to 0 μM) at 37 °C on a 3D orbital shaker. The absorbance
was measured after peptide addition at 600 nm using a Victor 2 plate reader
(Perkin-Elmer). MICs were deﬁned as the lowest peptide concentration after 24 h
at 37 °C. All tests were done in triplicate and the results are summarised in Table 1.
Haemolysis assay. Haemolysis was determined by incubating a 10% (vol/vol)
suspension of human erythrocytes with peptides. Erythrocytes were rinsed four
times in 10 mM phosphate buffer saline (PBS), pH 7.2, by repeated centrifugation
and re-suspension (3 min at 3000×g). Erythrocytes were incubated at room tem-
perature for 1 h in either deionised water (fully haemolysed control), PBS, or with
peptide in PBS. After centrifugation at 10,000×g for 5 min, the supernatant was
separated from the pellet, and the absorbance was measured at 550 nm. Absor-
bance of the suspension treated with deionised water deﬁned complete haemolysis.
The values given in Table 1 correspond to concentrations needed to kill a half of
the sample population (50% lysis of human erythrocytes) and are expressed as
median lethal concentrations—LC50. All tests were done in triplicate and the
results are summarised in Table 1.
Fluorescence imaging of bacteria. Bacterial cultures were centrifuged to give a
cell pellet, which was washed twice with 10 mM phosphate buffer (pH 7.4) before
being reconstituted in the buffer. One-hundred microlitres of the solution was
dispensed in an 8-well chamber (LabTek) with diluted (1/500) propidium iodide
(PI) (1 mgmL–1, Invitrogen CA, USA). The chambers with surface-settled bacteria
were mounted on a confocal microscope (IX 81, Olympus) equipped with an
incubation chamber at 37 °C. PI ﬂuorescence emission was monitored at 625 nm
for 60 min after the addition of the peptide to a ﬁnal concentration of 10 µM.
Recorded images were processed by ImageJ (NIH, USA, http://imagej.nih.gov/ij/)
to plot the number of ﬂuorescent (stain-dead) cells as a function of time. The
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values are expressed as a percentage of the total number of cells (taken as 100% for
each point).
Bacterial viability LIVE/DEAD® BacLight™ assays. Bacterial cultures (1 mL)
were centrifuged to give a cell pellet, which was washed twice with 10 mM phos-
phate buffer (pH 7.4) before being reconstituted in the same buffer to give OD600
nm = 0.008. A 100-µL aliquot of the solution was dispensed in an 8-well glass
chamber (LabTek) with LIVE/DEAD® BacLight™ bacterial viability kit (Invitro-
gen). The chambers with surface-settled bacteria (20 min) were mounted on a
confocal microscope (Olympus) equipped with an incubation chamber at 37 °C.
SYTO®9 and the ﬂuorescence emission of PI were monitored at 515 and 625 nm,
respectively, at different time points for 50 min after the addition of the capsids.
Recorded images (XY) were analysed using Fiji software to plot the number of dead
cells as a percentage of the total number of cells (taken as 100% for each point)
after subtracting the total number of dead cells in buffer alone (with no capsids
added).
Flow cytometry. Quantiﬁcation of labelled siRNA uptake was performed by ﬂow
cytometry. AF647-siRNA was assembled with the capsids by immediately adding to
the buffered capsid components at a peptide/nucleic acid (P/N) charge (+) ratio of
8:1 as previously described14. For a negative control, AF647-siRNA was incubated
with the C1 (−) strand at the same charge (−) ratio. For a positive control, AF647-
siRNA was assembled with Lipofectamine® RNAiMax (Lipo) according to the
proprietary protocols. After 4-h incubations with the obtained preparations, cells
were trypsinised and re-suspended in 200 µL PBS. AF647 ﬂuorescence was mea-
sured by ﬂow cytometry on a Cytek DxP8 FACScan (USA) and analysed using
FlowJo software (USA). At least 105 events were gated from each ≥106 subset
measured for each sample by forward scatter and side scatter on the 488 or 633 nm
lasers to extract and analyse 104 single viable cells. From the untreated control cells,
incubated with 200 µL Opti-MEM containing no siRNA and no peptide, a negative
population was taken as 0% negative. This gate was then used on all other samples
to measure the relative population of negative (no siRNA) and positive (siRNA)
cells, which was expressed in percentage.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within this paper and its supplementary information ﬁles as well
as from the authors.
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